GMO Insulin Causes Type 1 Diabetes in Type 2 Diabetics, Study Finds
Last year, we reported on the dangers of insulin therapy for type 2 diabetics, following the publication of a study comprised of almost 85,000 type 2 diabetic patients that found insulin monotherapy doubled their risk of all-cause mortality, in addition to significantly increasing their risk for diabetes-related complications and cancer. Insulin monotherapy resulted in:
2.0 times more myocardial infarctions.
1.7 time more major adverse cardiac events
1.4 time more strokes
3.5 times more renal complications
2.1 time more neuropathy
1.2 times more eye complications
1.4 times more cancer
2.2 times more deaths
Now, a new study published in the Journal of Clinical Endocrinology & Metabolism titled, "Insulin administration may trigger type 1 diabetes in Japanese type 2 diabetes patients with type 1 diabetes high-risk HLA class II and the insulin gene VNTR genotype," is shedding light on a possible explanation for why insulin treatment may accelerate morbidity and mortality in type 2 diabetics. The study revealed that giving genetically susceptible type 2 diabetes patients recombinant insulin can trigger their bodies to target their own insulin producing cells for autoimmune destruction, effectively producing 'double diabetes': type 1 and type 2, as a result.
The Japanese study took 6 patients (4 men and 2 women) with type 2 diabetes, none of whom had previously received insulin therapy nor had markers for autoantibodies to their own insulin (e.g. GAD65). All patients were found to have the type 1 diabetes susceptibility gene known as type 1 diabetes high risk HLA class II (IDDM1) Continue reading